Advisory Services Network, LLC Adma Biologics, Inc. Transaction History

Advisory Services Network, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $1,235 - $1,940	500 New	500 $1,000
Q3 2021 Nov 05, 2021	SELL	$1.13 - $1.65 $565 - $825	-500 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.51 - $2.07 $755 - $1,035	500 New	500 $1,000
Q1 2021 May 24, 2021	SELL	$1.67 - $2.95 $2,505 - $4,425	-1,500 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$1.8 - $2.56 $2,700 - $3,840	1,500 New	1,500 $3,000
Q2 2020 Aug 10, 2020	SELL	$2.42 - $3.29 $7,260 - $9,870	-3,000 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$3.89 - $5.15 $3,890 - $5,150	1,000 Added 50.0%	3,000 $12,000
Q3 2018 Nov 02, 2018	SELL	$4.39 - $6.85 $3,292 - $5,137	-750 Reduced 27.27%	2,000 $12,000
Q2 2018 Jul 27, 2018	BUY	$4.39 - $5.44 $4,609 - $5,712	1,050 Added 61.76%	2,750 $17,000
Q1 2018 Apr 23, 2018	BUY	$3.21 - $5.21 $3,210 - $5,210	1,000 Added 142.86%	1,700 $0
Q4 2017 Feb 08, 2018	BUY	$2.06 - $3.24 $1,442 - $2,268	700	700 $2,000

326

190M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.31B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.